argenx to Present at Upcoming Investor Conferences

Rhea-AI Summary

June 1, 2022 - argenx (ARGX), a company focused on autoimmune disease treatments, will participate in several key investor conferences this month. Events include the Jefferies 2022 Global Healthcare Conference on June 8 at 1:00 p.m. ET in New York, the Goldman Sachs 43rd Annual Global Healthcare Conference on June 15 at 3:20 p.m. PT in California, and the JMP Securities Life Sciences Conference also on June 15 in New York. Further details can be found on argenx's website.

June 1, 2022

Breda, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that members of management will participate in several upcoming investor conferences in June:

• Jefferies 2022 Global Healthcare Conference. Fireside chat on Wednesday, June 8, 2022 at 1:00 p.m. ET in New York, NY.
  
  
• Goldman Sachs 43^rd Annual Global Healthcare Conference. Fireside chat on Wednesday, June 15, 2022 at 3:20 p.m. PT in Rancho Palos Verdes, CA.
  
  
• JMP Securities Life Sciences Conference. Management will participate in investor meetings on Wednesday, June 15, 2022 in New York, NY.
  
  

Additional information regarding these events will be available on the Investors section of the argenx
website at argenx.com/investors.

About argenx

argenx is a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases. Partnering with leading academic researchers through its Immunology Innovation Program (IIP), argenx aims to translate immunology breakthroughs into a world-class portfolio of novel antibody-based medicines. argenx developed and is commercializing the first-and-only approved neonatal Fc receptor (FcRn) blocker in the U.S. and Japan. The Company is evaluating efgartigimod in multiple serious autoimmune diseases and advancing several earlier stage experimental medicines within its therapeutic franchises. For more information, visit www.argenx.com and follow us on LinkedIn, Twitter, and Instagram.

For further information, please contact:

Media:

Kelsey Kirk
kkirk@argenx.com

Investors:

Beth DelGiacco
bdelgiacco@argenx.com

Michelle Greenblatt
mgreenblatt@argenx.com

FAQ

What conferences will argenx participate in June 2022?

argenx will participate in the Jefferies 2022 Global Healthcare Conference on June 8, the Goldman Sachs 43rd Annual Global Healthcare Conference on June 15, and the JMP Securities Life Sciences Conference on the same day.

What is the date and time of the Jefferies Conference for argenx?

The Jefferies 2022 Global Healthcare Conference will be held on June 8, 2022, at 1:00 p.m. ET.

Where is the Goldman Sachs 43rd Annual Global Healthcare Conference taking place?

The Goldman Sachs 43rd Annual Global Healthcare Conference will take place in Rancho Palos Verdes, California on June 15, 2022.

How can I find more information about argenx's investor events?

Additional information regarding argenx's investor events is available on their official website in the Investors section.